Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Can J Infect Dis Med Microbiol ; 2023: 9968774, 2023.
Article in English | MEDLINE | ID: covidwho-2318592

ABSTRACT

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has impacted healthcare services and outcomes. We aimed to investigate healthcare resource utilization and early health outcomes of infants born to mothers with perinatal SARS-CoV-2 infection. Methods: The study included all infants born alive between February 1, 2020, and April 30, 2021, in British Columbia. We used linked provincial population-based databases including data on COVID-19 testing, birth, and health information for up to one year from birth. Perinatal COVID-19 exposure for infants was defined being born to mothers with a positive test for SARS-CoV-2 infection during pregnancy or at delivery. Cases of COVID-19-exposed infants were matched with up to four non-exposed infants by birth month, sex, birthplace, and gestational age in weeks. Outcomes included hospitalizations, emergency department visits, and in-/outpatient diagnoses. Outcomes were compared between groups using conditional logistic regression and linear mixed effects models including effect modification by maternal residence. Results: Among 52,711 live births, 484 infants had perinatal exposure to SARS-CoV-2, an incidence rate of 9.18 per 1000 live births. Exposed infants (54.6% male) had a mean gestational age of 38.5 weeks, and 99% were born in hospital. Proportions of infants requiring at least one hospitalization (8.1% vs. 5.1%) and at least one emergency department visit (16.9% vs. 12.9%) were higher among the exposed vs. unexposed infants, respectively. Among infants from the urban area, those with exposure were more likely to have respiratory infectious diseases (odds ratio: 1.74; 95% confidence intervals: 1.07, 2.84), compared with those without exposure. Interpretation. In our cohort, infants born to mothers with SARS-CoV-2 infection have increased healthcare demands in their early infancy, which warrants further investigation.

2.
Emerg Med Australas ; 35(3): 483-488, 2023 06.
Article in English | MEDLINE | ID: covidwho-2315503

ABSTRACT

OBJECTIVES: To examine workload, thermal discomfort and heat-related symptoms among healthcare workers (HCWs) in an Australian ED during the COVID-19 pandemic. METHODS: A cross-sectional study design was employed among HCWs in an ED at a metropolitan hospital in Brisbane, Australia. Respondents provided demographic information including their self-reported age, sex, height, weight, role (e.g. doctor, nurse), and whether they wore personal protective equipment (PPE) during their shift, rated as either Full PPE, Partial PPE, or usual uniform or scrubs. The workload of HCWs was assessed with the National Aeronautics and Space Administration's task load index (NASA-TLX). Thermal discomfort was evaluated using scales from the International Organisation for Standardisation. Responders rated their subjective heat illness using the Environmental Symptoms Questionnaire. RESULTS: Fifty-nine HCWs completed the survey (27 male, 31 female, one prefer not to answer). Overall workload from the NASA-TLX was 64.6 (interquartile range [IQR] 56.5-73.3) for doctors, 72.5 (IQR 63.3-83.3) for nurses and 66.7 (IQR 58.3-74.17) for other staff, representing moderate to high ratings. Eighty-one percent reported thermal sensation to be slightly warm, warm, or hot, and 88% reported being uncomfortable, ranging from slightly to extremely. Ninety-seven percent reported at least one heat-strain symptom. More than 50% reported light-headedness or headache and approximately 30% reported feeling dizzy, faint, or weak. CONCLUSIONS: ED HCWs experience thermal discomfort when wearing PPE. Combined with their workloads, HCWs experienced symptoms related to heat strain. Therefore, careful consideration should be given to managing heat strain among HCWs when wearing PPE in an ED.


Subject(s)
COVID-19 , Male , Humans , Female , COVID-19/epidemiology , COVID-19/prevention & control , Workload , Hot Temperature , Pandemics/prevention & control , Cross-Sectional Studies , Australia/epidemiology , Personal Protective Equipment , Health Personnel , Surveys and Questionnaires , Emergency Service, Hospital
3.
Emergency Medicine Australasia ; 34(6):1031-1033, 2022.
Article in English | CINAHL | ID: covidwho-2136533

ABSTRACT

The article presents the discussion on various topics in the journal. Topics include database linkage study showing an association between ambulance offload times, 30-day mortality, and ambulance reattendance rates for patients with chest pain;and importantly fluid administration in the standard fluid group not strictly protocolised.

4.
Neonatology ; 119(5): 619-628, 2022.
Article in English | MEDLINE | ID: covidwho-2020583

ABSTRACT

INTRODUCTION: Our objective was to compare neonatal outcomes and resource use of neonates born to mothers with SARS-CoV-2 positivity during pregnancy with neonates born to mothers without SARS-CoV-2 positivity. METHODS: We conducted a two-country cohort study of neonates admitted between January 1, 2020, and September 15, 2021, to tertiary neonatal intensive care unit (NICU) in Canada and Sweden. Neonates from mothers who were SARS-CoV-2 positive during pregnancy were compared with three randomly selected NICU neonates of mothers who were not test-positive, matched on gestational age, sex, and birth weight (±0.25 SD). Subgroup analyses were conducted for neonates born <33 weeks' gestation and mothers who were SARS-CoV-2 positive ≤10 days prior to birth. Primary outcome was duration of respiratory support. Secondary outcomes were in-hospital mortality, neonatal morbidity, late-onset sepsis, receipt of breast milk at discharge, and length of stay. RESULTS: There were 163 exposed and 468 matched neonates in Canada, and 303 exposed and 903 matched neonates in Sweden. There was no statistically significant difference in invasive or noninvasive respiratory support durations, mortality, respiratory and other neonatal morbidities, or resource utilizations between two groups in both countries in entire cohort and in subgroup analyses. Receipt of breast milk at discharge was lower in the Canadian neonates of mothers who were SARS-CoV-2 positive ≤10 days before birth (risk ratio 0.68, 95% CI: 0.57-0.82). CONCLUSION: Maternal SARS-CoV-2 positivity was not associated with increased durations of respiratory support, morbidities, mortality, or length of hospital stay in Canada and Sweden among neonates admitted to tertiary NICU.


Subject(s)
COVID-19 , Pregnancy Complications, Infectious , COVID-19/epidemiology , Canada/epidemiology , Cohort Studies , Female , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical , Intensive Care Units, Neonatal , Male , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Outcome , SARS-CoV-2
5.
Emergency Medicine Australasia ; 34(4):661-663, 2022.
Article in English | CINAHL | ID: covidwho-1973514

ABSTRACT

The article highlights that balanced multielectrolyte solution (BMES) has been touted as superior to 0.9% saline because of concerns about iatrogenic acute kidney injury and hyperchloraemic metabolic acidosis. It also discusses that patients who have suffered out- of-hospital cardiac arrest frequently have cardiogenic shock.

6.
Emerg Med Australas ; 34(3): 475-477, 2022 06.
Article in English | MEDLINE | ID: covidwho-1865069
7.
Emerg Med Australas ; 34(1): 141-143, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1662226
9.
Emergency Medicine Australasia ; 33(1):184-187, 2021.
Article in English | Academic Search Complete | ID: covidwho-1080710
11.
Emergency Medicine Australasia ; 32(6):1096-1098, 2020.
Article in English | Academic Search Complete | ID: covidwho-936605

ABSTRACT

The article offers briefs from other periodicals related to medical care industry. Topics include the use of ultrasound for diagnosing shoulder dislocation compared to standard pre-reduction X-rays;dexamethasone in COVID patients not needing respiratory support but with prolonged symptoms;and Dexamethasone in RECOVERY is one piece in the COVID puzzle, and RECOVERY Platform is a ‘super-trial' that rapidly enrolled in hospitalized COVID cases.

SELECTION OF CITATIONS
SEARCH DETAIL